Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing
Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136